• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LP BARRX UNKNOWN HALO 360; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LP BARRX UNKNOWN HALO 360; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES Back to Search Results
Model Number UNKNOWN HALO 360
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stenosis (2263); Blood Loss (2597)
Event Date 07/26/2020
Event Type  Injury  
Manufacturer Narrative
Title outcomes of radiofrequency ablation by manual versus self-sizing circumferential balloon catheters for the treatment of dysplastic b arrett¿s esophagus: a multicenter comparative cohort study source american society for gastrointestinal endoscopy, 2020(1-25), date of acceptance: 26 july 2020.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to literature source of study performed, 90 patients were treated with halo 360 express catheter, 8 patients developed early stricture formation at a median of 53 days after first ablation.6 patients developed the stricture after use of the 12 joules ablation dose and 1 patient experienced a delayed stricture at 203 days after first ablation.All strictures were successfully managed with endoscopic dilation using bougie dilation, balloon dilation, or a combination of both.Patients underwent a median of 2 dilations for stricture resolution.1 patient with post operative bleeding had coronary artery disease and peripheral vascular disease, requiring dual antiplatelet therapy with aspirin and clopidogrel, which increases the risk of intra-procedural and post-procedural bleeding.Clopidogrel was held for the procedure and resumed the following day.16 days later, the patient presented with hematemesis.Endoscopy revealed circumferential esophageal ulcers with active oozing of blood.No endoscopic therapy was applied given diffuse oozing and the lack of a single treatable source.The patient was treated supportively with blood transfusion and was discharged without further bleeding.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN HALO 360
Type of Device
ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES
Manufacturer (Section D)
COVIDIEN LP BARRX
covidien gi solutions
sunnyvale CA 94085 4022
Manufacturer (Section G)
COVIDIEN LP BARRX
covidien gi solutions
sunnyvale CA 94085 4022
Manufacturer Contact
amy beeman
161 cheshire lane, suite 100
plymouth, MN 55441
7632104064
MDR Report Key10525203
MDR Text Key206774216
Report Number3004904811-2020-00027
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 09/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/11/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN HALO 360
Device Catalogue NumberUNKNOWN HALO 360
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/25/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
-
-